(Q46124376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

György Bodoky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Benedek Gyöngyösi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Éva Végh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Balázs Járay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Eszter Székely

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Zsuzsa Schaff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

András Kiss

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

7 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

Journal of Histochemistry and Cytochemistry

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

547-555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804874%20AND%20SRC:MED&resulttype=core&format=json

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Fine needle aspiration of non-small cell lung cancer: current state and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA involvement in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Molecular approaches to treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Upregulation of microRNA-224 confers a poor prognosis in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

The microcosmos of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Underexpression of miR-224 in methotrexate resistant human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Diagnostic and prognostic molecular markers in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Molecular profiling of thin-prep FNA samples in assisting clinical management of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Detection of microRNAs in archival cytology urine smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277

microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2F0022155414537277